You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC / CE

Does Where You Live Dictate UTI Care for Women?

  • Authors: News Author: Heidi Splete; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 4/16/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/16/2022, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for women's health clinicians/obstetricians/gynecologists, family medicine practitioners, internists, nurses, pharmacists, urologists, and other members of the health care team for patients with urinary tract infection.

The goal of this activity is to describe rural-urban differences in temporal trends and risk for inappropriate antibiotic use by agent and duration among women with uncomplicated urinary tract infection, based on an observational cohort study using the IBM MarketScan Commercial Database (2010-2015).

Upon completion of this activity, participants will:

  • Assess rural-urban differences in temporal trends and risk for inappropriate antibiotic use by agent and duration among women with uncomplicated urinary tract infection, based on an observational cohort study
  • Evaluate the clinical and public health implications of rural-urban differences in temporal trends and risk for inappropriate antibiotic use by agent and duration among women with uncomplicated urinary tract infection, based on an observational cohort study
  • Outline implications for the healthcare team


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


News Author

  • Heidi Splete

    Freelancer writer, Medscape

    Disclosures

    Disclosure: Heidi Splete has disclosed no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor/CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Nurse Planner

  • Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-21-290-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Does Where You Live Dictate UTI Care for Women?

Authors: News Author: Heidi Splete; CME Author: Laurie Barclay, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 4/16/2021

Valid for credit through: 4/16/2022, 11:59 PM EST

processing....

Clinical Context

Appropriate antibiotic prescribing as recommended by current guidelines is important for clinical and public health, as inappropriate antibiotic use is linked to increased risk for treatment failure, adverse events, antibiotic resistance, and healthcare costs. However, most antibiotic prescriptions for uncomplicated urinary tract infections (UTIs) are written for nonrecommended agents and durations and are therefore suboptimal.

The US Department of Health and Human Services prioritizes leveling of rural health disparities, but how these affect antibiotic treatment for UTIs has been previously undetermined.

Study Synopsis and Perspective

Women living in rural areas were significantly more likely than those in urban areas to receive inappropriate antibiotic prescriptions for UTIs, based on data from an observational cohort study of more than 600,000 women.

Uncomplicated UTIs are common among otherwise healthy women in the United States, and certain antibiotics are recommended as first-line therapy, write Abbye W. Clark, MD, from Washington University, St. Louis, and colleagues.

"However, most antibiotic prescriptions for uncomplicated UTIs are suboptimal because they are written for nonrecommended agents and durations," they note.

Addressing rural health disparities has become a focus in the United States, and previous studies of respiratory tract infections have shown differences in antibiotic prescribing based on geographic region; "however, no large-scale studies have evaluated rural-urban differences in inappropriate outpatient antibiotic prescribing for UTIs," they add.

In a study published in Infection Control & Hospital Epidemiology, the researchers identified 670,450 women aged 18-44 years who received oral antibiotics for uncomplicated UTIs between 2010 and 2015, using a commercial insurance database to determine diagnosis and antibiotic prescription information. Women were defined as urban if they lived in a metropolitan statistical area of at least 50,000 inhabitants (86.2%); all other women were defined as rural (13.8%). The median age was 30 years for both groups.

Overall, 46.7% of the women received prescriptions for inappropriate antibiotics and 76.1% received antibiotics for inappropriate durations.

Antibiotics and durations were defined as appropriate or inappropriate based on current clinical guidelines. "We classified first-line agents (nitrofurantoin, trimethoprim-sulfamethoxazole [TMP-SMX], and fosfomycin) as appropriate and non-first-line agents (fluoroquinolones and β-lactams) as inappropriate," the researchers write.

The regimens classified as appropriate duration were "nitrofurantoin 5-day regimen, TMP-SMX (including TMP monotherapy) 3-day regimen, fosfomycin 1-day regimen, fluoroquinolones 3-day regimen, and β-lactams 3-7-day regimens. All other regimens were classified as inappropriate duration," they note.

More Rural Women Receive Long-Duration Antibiotics

In a multivariate analysis, similar percentages of antibiotics for rural and urban women consisted of inappropriate agents (45.9% vs 46.9%, respectively) including use of fluoroquinolones (41.0% vs 41.7%) and β-lactams (4.8% vs 5.0%).

However, across all antibiotics, women in rural areas were more likely than women in urban areas to receive prescriptions for inappropriate durations (83.9% vs 74.9%; adjusted risk ratio, 1.10).

The percentage of women who received inappropriate antibiotic agents was not significantly different according to geographic region of the country.

From 2011 to 2015, the quarterly proportion of women overall who received inappropriate agents and antibiotics for inappropriate durations decreased slightly (from 48.5% to 43.7% and from 78.3% to 73.4%, respectively), the researchers note.

The study findings were limited by several factors including the potentially lenient definition of antibiotic duration, a study population that disproportionately oversampled from the South and undersampled from the West, use of ZIP codes to determine rural vs urban status, lack of data on race and income, and lack of access to urine culture results, the researchers note.

However, "our study identified rural-urban differences in antibiotic prescribing, including an actionable disparity in the duration of antibiotics that disproportionately affects women who live in rural locations," they write.

"Given the large quantity of inappropriate prescriptions annually in the United States, as well as the negative patient- and society-level consequences of unnecessary exposure to antibiotics, antimicrobial stewardship interventions are needed to improve outpatient UTI antibiotic prescribing, particularly in rural settings," they conclude.

Data Support Need for Education and Stewardship

"This manuscript provides valuable information to all women's health providers regarding the importance of antibiotic stewardship," David M. Jaspan, DO, and Natasha Abdullah, MD, from the Einstein Medical Center, Philadelphia, said in an interview. Whether urban or rural, more than 45% of the patients received inappropriate non-first-line treatment and 76% of the prescriptions were for an inappropriate duration (98.8% for longer durations than recommended, 1.2% for shorter durations), they emphasized.

"The potential negative impact of antibiotic resistance, coupled with the potential for increased side effects, should prompt providers to ensure that when treating uncomplicated UTIs in women, that the choice of treatment and the duration of treatment is tailored to the patient's needs," Dr. Jaspan and Dr. Abdullah said.

To improve antibiotic prescribing, especially at the local and regional level, "We encourage providers to familiarize themselves with local information as it pertains to known resistance when prescribing empiric treatment regimens for uncomplicated UTIs," they said.

The study was supported by the National Center for Advancing Translational Sciences at the National Institutes of Health. Lead author Dr Clark, as well as Dr Jaspan and Dr Abdullah, had no financial conflicts to disclose.

Infect Control Hosp Epidemiol. Published online February 24, 2021.[1]

Study Highlights

  • This observational cohort study used the IBM MarketScan Commercial Database (2010-2015) to identify 670,450 US commercially insured women aged 18-44 years with uncomplicated UTI treated with oral antibiotics.
  • Antibiotic agents and durations were classified as appropriate vs inappropriate on the basis of clinical guidelines, and rural-urban status was defined by residence in a metropolitan statistical area.
  • Modified Poisson regression allowed determination of associations between rural-urban status and inappropriate antibiotic receipt, adjusting for patient- and provider-level factors.
  • Multivariable logistic regression allowed estimation of antibiotic use trends by rural-urban status.
  • Among women with uncomplicated UTI, 46.7% received antibiotic prescriptions for inappropriate agents and 76.1% for inappropriate durations.
  • There was little rural-urban difference in use of inappropriate agents in the overall population, but there was variation across geographic regions, provider specialties, and time.
  • Rural vs urban women were more likely to receive prescriptions with inappropriate durations (adjusted risk ratio, 1.10; 95% confidence interval, 1.10–1.10), consistent across subgroups.
  • From 2011 to 2015, the proportion of patients who received inappropriate agents and durations declined slightly, going from 48.5% to 43.7% and from 78.3% to 73.4%, respectively.
  • Over time, rural-urban differences varied by agent (duration outcome only), geographic region, and provider specialty.
  • The investigators concluded that inappropriate antibiotic prescribing is very common for uncomplicated UTI treatment, that rural women are more likely to receive inappropriately long antibiotic durations, and that inappropriate antibiotic use for UTI (both by agent and duration) declined slightly over time.
  • The findings mandate antimicrobial stewardship interventions to improve outpatient UTI antibiotic prescribing and to reduce unnecessary antibiotic exposure and duration, which disproportionately affects women in rural locations.
  • Existing recommendations to promote outpatient antibiotic stewardship include personal and policy commitment to change, reporting progress, and enhancing education around best practices.
  • Possible explanations for regional variability in agent use may include local patterns of uropathogen resistance, especially for Escherichia coli, the leading bacterial cause of UTIs, but such data are unavailable.
  • In settings with known local resistance, first-line TMP-SMX should be avoided; first-line nitrofurantoin is appropriate because of minimal resistance, but research shows that clinicians often prescribe non-first-line agents for other conditions.
  • Patient- and provider-level factors may also explain rural-urban differences in use of appropriate antibiotic durations, such as distance to healthcare.
  • Rural women may receive longer treatment to avoid treatment failure-related healthcare encounters requiring travel.
  • Late-career physicians are more prevalent in rural locations and are more likely to prescribe antibiotics for longer durations.
  • Study limitations include possibly too lenient guideline-based definition of inappropriate duration, lack of generalizability beyond this database of commercially insured women, and lack of data on race, ethnicity, income or urine culture results.
  • Future research should target identifying, disseminating, and implementing guideline-concordant antibiotic prescribing in rural settings.

Clinical Implications

  • Inappropriate antibiotic use for uncomplicated UTI is very common, and rural women are more likely to receive inappropriately long durations.
  • Patient- and provider-level factors and local patterns of antibiotic resistance may explain rural-urban differences in use of appropriate antibiotic durations.
  • Implications for the Health Care Team: The findings mandate antimicrobial stewardship interventions and interprofessional collaboration to improve outpatient UTI antibiotic prescribing.

 

Earn Credit

  • Print